Peralta et al evaluated patients with chronic kidney disease (CKD) using 3 markers (creatinine, cystin C, and the urine albumin-to-creatinine ratio). These can help to identify a patient who may progress to end-stage renal disease or die. The authors are from San Francisco VA Medical Center, University of California at San Francisco, University of Alabama, University of Vermont and Emory University.
